Bioactivity:

BIIB068 is an selective, reversible and orally active BTK inhibitor (IC50 = 1 nM, Kd = 0.3 nM). BIIB068 is 400 times more selective for BTK than other kinases.

CAS nr:

1798787-27-5

Purity:

98%

Molecular Weight:

435,52

SMILES:

O=C(N1CC(OC(C)C)C1)NCC2=CC=C(C3=NC(NC4=CN(C)N=C4)=NC=C3)C=C2C

Formula:

C23H29N7O2

Pathway:

Angiogenesis,Tyrosine Kinase/Adaptors

Target:

BTK,BTK